Back to top
more

Humana (HUM)

(Delayed Data from NYSE)

$256.14 USD

256.14
850,473

-0.48 (-0.19%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $256.25 +0.11 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 1% (243 out of 246)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Humana or Anthem: Which is a Better Health Insurance Stock?

by Zacks Equity Research

Both Humana and Anthem stocks look attractive in a thriving health insurance industry.

    Zacks Equity Research

    Do Options Traders Know Something About Humana (HUM) Stock We Don't?

    by Zacks Equity Research

    Investors need to pay close attention to Humana (HUM) stock based on the movements in the options market lately.

      Zacks Equity Research

      Molina Healthcare Clinches Medicaid Contracts in Florida

      by Zacks Equity Research

      Molina Healthcare's (MOH) unit wins Medicaid Managed Care contracts from the Florida Agency.

        Zacks Equity Research

        UnitedHealth Senior Notes Receive Rating Action From Moody's

        by Zacks Equity Research

        Moody's assigns rating to $4 billion senior unsecured debt of UnitedHealth (UNH). Outlook remains stable.

          Zacks Equity Research

          3 Solid Reasons to Add WellCare Health to Your Portfolio

          by Zacks Equity Research

          Riding high on three impressive factors, WellCare Health (WCG) holds great potential to generate lucrative returns for investors.

            Zacks Equity Research

            What Makes UnitedHealth (UNH) Stand Out in Its Industry?

            by Zacks Equity Research

            UnitedHealth (UNH) stands out by virtue of its immense scale and size.

              Zacks Equity Research

              Humana (HUM) Soars to a 52-Week High, Time to Cash Out?

              by Zacks Equity Research

              Humana Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for HUM for clues.

                Zacks Equity Research

                UnitedHealth (UNH) Hits 52-Week High: Is More Upside Left?

                by Zacks Equity Research

                UnitedHealth (UNH) hits 52-week high on dividend hike, share buyback renewal, and agreements with lab and diagnostic companies.

                  Zacks Equity Research

                  Humana (HUM) and Monida Ink Deal, Enhances In-Network Access

                  by Zacks Equity Research

                  Humana (HUM) enters into an agreement with Monida to provide better in-network access to Humana Medicare Advantage members.

                    Zacks Equity Research

                    UnitedHealth Hikes Quarterly Dividend by 20%, Okays Buyback

                    by Zacks Equity Research

                    UnitedHealth (UNH) to raise its quarterly dividend by 20%. The company also refreshes its share buyback program in support of disciplined capital deployment.

                      Zacks Equity Research

                      Ensign Group Expands in Arizona With Sun West Choice Buyout

                      by Zacks Equity Research

                      Ensign Group (ENSG) acquires the operations of Sun West Choice Healthcare and Rehabilitation.

                        Zacks Equity Research

                        Wellcare (WCG) Downgraded by Moody's on Meridian Buyout News

                        by Zacks Equity Research

                        Moody's places a downgrade rating review of WellCare Health Plans (WCG) and its unit WellCare of Florida.

                          Zacks Equity Research

                          Community Health Sells Byrd Regional & Tennova Healthcare

                          by Zacks Equity Research

                          Community Health (CYH) recently closes the sale of 60-bed Byrd Regional Hospital and its associated assets besides the 85-bed Tennova Healthcare.

                            Zacks Equity Research

                            Humana (HUM) Up 3% Since Earnings Report: Can It Continue?

                            by Zacks Equity Research

                            Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                              Mark Vickery headshot

                              Top Research Reports for Facebook, Intel & Boeing

                              by Mark Vickery

                              Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Intel (INTC) and Boeing (BA).

                                Zacks Equity Research

                                8 Solid Reasons to Retain United Health in Your Portfolio

                                by Zacks Equity Research

                                Riding high on eight important factors, United Health (UHS) holds great potential to generate lucrative returns to investors.

                                  Zacks Equity Research

                                  UnitedHealth Extends LabCorp Ties, Signs Quest Diagnostic Deal

                                  by Zacks Equity Research

                                  UnitedHealth (UNH) agrees with laboratories and diagnostic companies for value based care.

                                    Zacks Equity Research

                                    Centene Banks on Investments and Acquisitions for Growth

                                    by Zacks Equity Research

                                    Centene???s (CNC) numerous acquisitions and investments poise it well for inorganic growth.

                                      Zacks Equity Research

                                      Zacks Industry Outlook Highlights: UnitedHealth, Anthem, Aetna, Cigna and Humana

                                      by Zacks Equity Research

                                      Zacks Industry Outlook Highlights: UnitedHealth, Anthem, Aetna, Cigna and Humana

                                        Zacks Equity Research

                                        Tenet (THC) Hits 52-Week High on Solid Q1, Raises'18 View

                                        by Zacks Equity Research

                                        Riding high on better-than-expected first-quarter results and a rating upgrade, Tenet (THC) touches a 52 week-high in yesterday's trading session.

                                          Zacks Equity Research

                                          5 Reasons Why You Must Add Humana (HUM) to Your Portfolio

                                          by Zacks Equity Research

                                          Humana (HUM) looks promising to garner better returns for investors owing to five factors.

                                            Zacks Equity Research

                                            Triple-S Management (GTS) Soars to a 52-Week High, Time to Cash Out?

                                            by Zacks Equity Research

                                            Triple-S Management Corporation is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for GTS for clues.

                                              Mark Vickery headshot

                                              Top Research Reports for General Dynamics, Enbridge & CSX Corporation

                                              by Mark Vickery

                                              Today's Research Daily features new research reports on 16 major stocks, including General Dynamics (GD), Enbridge (ENB) and CSX Corporation (CSX).

                                                Zacks Equity Research

                                                5 Reasons to Add WellCare Health Plans to Your Portfolio

                                                by Zacks Equity Research

                                                WellCare Health Plans (WCG) looks lucrative, promising better yield for investors on the back of five factors.

                                                  Zacks Equity Research

                                                  Here's Why Teladoc Reaches a 52 Week High, Stock Up 22%

                                                  by Zacks Equity Research

                                                  Teladoc's (TDOC) robust results and a favorable guidance increase the stock price.